Our Team

I have extensive experience in interacting with the pharmaceutical industry having been integrally involved in the design and implementation of randomized controlled trials with Fujisawa (Astellas) in the field of transplant-related immunosuppression. Furthermore, I am currently completing study designs for clinical trials with both AbbVie and Alcresta and am a clinical expert advisor for both companies. I also currently have roles on the Scientific Advisory Boards of Caligenix and EDP Biotech and am a clinical advisor for both Freedom Health and Woodland Pharma. I have more recently expanded into drug development and am a founding member of Sefacor Inc, a biopharmaceutical company developing a novel anti-cancer medication targeting high grade glioma and pancreatic cancer.

I have enjoyed a reasonably successful career as an innovation leader in the pharmaceutical industry. My research spans development and innovative aspects of diagnostic tests, Nutraceutical and drug delivery for the past 30 years. I have started 4 pharmaceutical companies two in USA and two in India. I own three patents

Our innovative drug delivery system is to improve 45% approved drugs, which are compromised in delivery system that leads to high toxicity. I have designed a system where not only we can improve the efficacy but reduce the toxicity of drug.

Adjunct Professor of Environmental and Population Health, Tufts University School of Veterinary Medicine
Postdoctoral Fellow, University of Texas Southwestern Medical Center, laboratory of Drs. Michael Brown and Joseph Goldstein
EMBO Fellow, Universitat Zurich, Lab of Dr. Ernst Hafen
Ph.D. University of California, Berkeley, laboratory of Prof. Robert Tjian
B.A. Biology, University of Delaware, Dean’s Scholar

I have enjoyed a reasonably successful career as a thought leader in the pharmaceutical industry at Director level or above and am the founder of Woodland Pharmaceuticals.